Poseida Therapeutics, Inc. Operating Lease Right-of-Use Assets
Poseida Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $19.05 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-11-07
- 2024-09-30: Operating Lease, Right-of-Use Asset $19.05M.
- 2024-06-30: Operating Lease, Right-of-Use Asset $19.96M.
- 2024-03-31: Operating Lease, Right-of-Use Asset $20.86M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $21.73M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2024-09-30 | $19.05M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $19.96M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $20.86M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $21.73M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $22.57M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $23.40M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $24.21M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $25.09M 10-K · filed 2024-03-07 |
| 2022-09-30 | $27.00M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $27.98M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $28.95M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $26.18M 10-K · filed 2023-03-09 |
| 2021-09-30 | $25.19M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $26.07M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $26.94M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $24.99M 10-K · filed 2022-03-10 |
| 2020-09-30 | $25.07M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $20.14M 10-Q · filed 2020-08-20 |